List View Detail View 51-75 of 90 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 2 3 4 Next Product Clone Appl. Reg Cat# Size See more size options for this product on the previous page. Ultra-LEAF™ Purified anti-human GM-CSF Antibody BVD2-21C11 Neut RUO 502320 1 mg ¥118,690 Brilliant Violet 421™ anti-human GM-CSF Antibody BVD2-21C11 ICFC RUO 502323 25 tests ¥41,800 502324 100 tests ¥85,800 Purified anti-human GM-CSF Antibody BVD2-23B6 ELISA Capture, IP, WB RUO 502201 50 µg ¥23,320 502202 500 µg ¥30,360 Ultra-LEAF™ Purified anti-human GM-CSF Antibody BVD2-23B6 ELISA Capture, ELISPOT Capture, IP, Neut, WB RUO 502205 100 µg ¥18,260 502206 1 mg ¥24,740 502207 5 mg ¥89,480 502208 25 mg ¥233,730 502209 50 mg ¥390,770 502210 100 mg ¥561,580 APC anti-human CD114 (G-CSFR) Antibody LMM741 FC RUO 346107 25 tests ¥32,780 346108 100 tests ¥73,040 PE anti-human CD114 (G-CSFR) Antibody LMM741 FC RUO 346105 25 tests ¥29,480 346106 100 tests ¥69,740 PerCP/Cyanine5.5 anti-human CD114 (G-CSFR) Antibody LMM741 FC RUO 346109 25 tests ¥32,340 TotalSeq™-A1269 anti-human CD114 (G-CSFR) Antibody LMM741 PG RUO 346111 10 µg ¥81,180 TotalSeq™-B1269 anti-human CD114 (G-CSFR) Antibody LMM741 PG RUO 346115 10 µg ¥81,180 TotalSeq™-C1269 anti-human CD114 (G-CSFR) Antibody LMM741 PG RUO 346113 10 µg ¥81,180 LEGENDplex™ Human GM-CSF Capture Bead A7, 13X Multiplex - Component RUO 740106 100 tests (270 µL) ¥25,960 LEGENDplex™ Human GM-CSF Capture Bead A10, 13X Multiplex - Component RUO 740186 100 tests (270 µL) ¥25,960 LEGENDplex™ Human GM-CSF Capture Bead B5, 13X Multiplex - Component RUO 740362 100 tests (270 µL) ¥25,960 LEGENDplex™ Human GM-CSF Capture Bead A6, 13X Multiplex - Component RUO 740599 100 tests (270 µL) ¥25,960 LEGENDplex™ Human GM-CSF Capture Bead A4, 14X Multiplex - Component RUO 741114 100 tests (250 µL) ¥25,960 LEGEND MAX™ Human GM-CSF ELISA Kit ELISA RUO 432007 1 Pre-coated Plate ¥89,980 See more size options for this product on the next page. Results Per Page: 25 50 100 200 Previous 1 2 3 4 Next
Follow Us